Parnetti L, Palumbo B, Cardinali L, Loreti F, Chionne F, Cecchetti R, Senin U. Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia. Neurosci Lett. 1995 Jan 2;183(1-2):43-5. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)		 Cohort
(N)		 Measurement
Mean ± SD		 Method;
Assay Name;
Manufacturer		 Diagnostic
Criteria
NSE
(CSF)		 AD
(24)		 8.1 ± 3.4
ng/mL		 Radio Immunoassay;
Prolifigen;
Sangtec Medical		 McKhann et al., 1984
NSE
(CSF)		 CTRL-
CNC
(11)		 7.8 ± 2.4
ng/mL		 Radio Immunoassay;
Prolifigen;
Sangtec Medical
NSE
(CSF)		 VaD
(14)		 4.7 ± 1.8
ng/mL		 Radio Immunoassay;
Prolifigen;
Sangtec Medical		 Román et al., 1993
NSE
(Serum)		 AD
(24)		 15 ± 7.5
mg/mL		 Radio Immunoassay;
Prolifigen;
Sangtec Medical		 McKhann et al., 1984
NSE
(Serum)		 CTRL-
CNC
(11)		 14 ± 6.5
mg/mL		 Radio Immunoassay;
Prolifigen;
Sangtec Medical
NSE
(Serum)		 VaD
(14)		 11 ± 3.5
mg/mL		 Radio Immunoassay;
Prolifigen;
Sangtec Medical		 Román et al., 1993

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

AlzBiomarker

  1. AD vs CTRL : NSE (CSF)
  2. AD vs CTRL : NSE (Plasma and Serum)
  3. CTRL vs AD : NSE (CSF)
  4. CTRL vs AD : NSE (Plasma and Serum)
  5. VaD vs AD : NSE (CSF)
  6. VaD vs AD : NSE (Plasma and Serum)